Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment

NCT02550106 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2020-02-25

Study results available
· View outcomes & findings →

Summary

Evaluate the proportion of patients with an urticaria control test \[UCT\] score of greater than or equal to 12 at Week 12.

Conditions

Interventions

DRUG

OMALIZUMAB

sub cutaneous injections of 300 mg every 4 weeks until Week 8.

Sponsors & Collaborators

Principal Investigators

  • CLAIRE BERNIER TAUGOURDEAU · HOPITAL HOTEL DIEU - NANTES CEDEX 1

  • PASCAL JOLY · HOPITAL CHARLES NICOLLE - ROUEN CEDEX

  • LUDOVIC MARTIN · HOTEL DIEU - ANGERS CEDEX 9

  • GERARD GUILLET · CHR LA MILETRIE - POITIERS CEDEX

  • PATRICE PLANTIN · CHI DE CORNOUAILLE - QUIMPER CEDEX

  • ALAIN DUPUY · HOPITAL PONTCHAILLOU - RENNES CEDEX 9

  • EVELYNE COLLET · CHU SITE DU BOCAGE - DIJON CEDEX

  • ANNICK BARBAUD · HOPITAUX DE BRABOIS - VANDOEUVRE LES NANCY CEDEX

  • ZIAD REGUIAI · HOPITAL ROBERT DEBRE - REIMS CEDEX

  • FABIEN PELLETIER · HOPITAL JEAN MINJOZ - BESANCON CEDEX

  • DELPHINE STAUMONT SALLE · HOPITAL CLAUDE HURIEZ- LILLE CEDEX

  • JULIETTE JEGOU · CH DE CHALONS EN CHAMPAGNE - CHALONS EN CHAMPAGNE CEDEX

  • EMMANUELLE AMSLER · HOPITAL TENON - PARIS CEDEX 20

  • OLIVIER CHOSIDOW · HOPITAL HENRI MONDOR - CRETEIL

  • VINCENT DESCAMPS · HOPITAL BICHAT CLAUDE BERNARD - PARIS CEDEX 18

  • EMMANUEL MAHE · CH VICTOR DUPOUY - ARGENTEUIL CEDEX

  • LILIANE LAROCHE · HOPITAL AVICENNE - BOBIGNY CEDEX

  • GERMAINE GABISON · HOPITAL SAINT LOUIS - PARIS CEDEX 10

  • SELIM ARACTINGI · HOPITAL COCHIN - PARIS

  • LAURENCE BOUILLET · CHU DE GRENOBLE - LA TRONCHE

  • JEAN-JACQUES GROB · HOPITAL TIMONE - MARSEILLE CEDEX 05

  • FREDERIC CAMBAZARD · CHU SAINT ETIENNE - ST PRIEST EN JAREZ CEDEX

  • THIERRY BOYE · HIA SAINTE ANNE - TOULON CEDEX 9

  • JEAN-PHILIPPE LACOUR · HOPITAL DE L'ARCHET - NICE CEDEX 3

  • PHILIPPE BERBIS · HOPITAL NORD- MARSEILLE

  • LAURENT MEUNIER · HOPITAL CAREMEAU - NIMES CEDEX 9

  • FRANCOISE GIORDANO LABADIE · HOPITAL LARREY - TOULOUSE CEDEX 9

  • NADIA RAISON PEYRON · HOPITAL ST ELOI - MONTPELLIER CEDEX 5

  • MARIE CHRISTINE FERRIER LE BOUEDEC · CHU ESTAING - CLERMONT FERRAND

  • MARIE SYLVIE DOUTRE · HOPITAL DE HAUT LEVEQUE - PESSAC CEDEX

  • BRIGITTE MILPIED · HOPITAL ST ANDRE - BORDEAUX CEDEX

  • CHRISTOPHE BEDANE · HOPITAL DUPUYTREN - LIMOGES CEDEX 1

  • PHILIPPE MODIANO · HOPITAL ST VINCENT DE PAUL - LILLE CEDEX

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-22
Primary Completion
2016-01-11
Completion
2016-01-11

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02550106 on ClinicalTrials.gov